IBEX Limited (IBEX) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Sep 10, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IBEX SEC filings page.
IBEX Limited (IBEX) reported $644.1M in revenue for fiscal year 2026, up 15.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Margin expansion and cash conversion are improving as IBEX scales, but receivables growth increasingly ties operating cash to customer collections.
In FY2026, operating cash flow of$59.0M exceeded net income of$46.3M , indicating earnings were largely converting into collected cash rather than remaining accruals. After$27.8M of capital expenditure, however, only$31.2M remained as free cash flow, making reinvestment a meaningful claim on internally generated cash.
Gross margin widened from
IBEX carries almost no balance-sheet leverage: debt-to-equity was 0.0x and the current ratio was 2.1x in FY2026, so short-term coverage is not being created by borrowing. Accounts receivable grew
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of IBEX Limited's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
IBEX Limited has an operating margin of 8.5%, meaning the company retains $9 of operating profit per $100 of revenue. This strong profitability earns a score of 66/100, reflecting efficient cost management and pricing power. This is up from 8.3% the prior year.
IBEX Limited's revenue surged 15.4% year-over-year to $644.1M, reflecting rapid business expansion. This strong growth earns a score of 71/100.
IBEX Limited carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 93/100, indicating a strong balance sheet with room for future borrowing.
IBEX Limited's current ratio of 2.10 indicates adequate short-term liquidity, earning a score of 62/100. The company can meet its near-term obligations, though with limited headroom.
IBEX Limited has a free cash flow margin of 4.8%, earning a moderate score of 45/100. The company generates positive cash flow after capital investments, but with room for improvement.
IBEX Limited earns a strong 27.2% return on equity (ROE), meaning it generates $27 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 86/100. This is down from 27.5% the prior year.
IBEX Limited scores 5.96, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
IBEX Limited passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, IBEX Limited generates $1.27 in operating cash flow ($59.0M OCF vs $46.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
IBEX Limited earns $58.72 in operating income for every $1 of interest expense ($55.0M vs $936K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
IBEX Limited generated $164.3M in revenue in Q4 2026. This represents an increase of 11.6% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.
IBEX Limited's EBITDA was $15.4M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 6.4% from the same quarter a year earlier. Against the prior quarter it is down 27.6%.
IBEX Limited reported $8.7M in net income in Q4 2026. This represents a decrease of 8.8% from the same quarter a year earlier. Against the prior quarter it is down 34.4%.
IBEX Limited earned $0.59 per diluted share (EPS) in Q4 2026. This represents a decrease of 10.6% from the same quarter a year earlier. Against the prior quarter it is down 33.7%.
Cash & Balance Sheet
IBEX Limited generated $21.7M in free cash flow in Q4 2026, representing cash available after capex. This represents a decrease of 4.9% from the same quarter a year earlier. Against the prior quarter it is up 228.6%.
IBEX Limited held $32.6M in cash against $777K in long-term debt as of Q4 2026, with $85.5M of liabilities due within a year.
Not reported for Q4 2026.
Margins & Returns
IBEX Limited's gross margin was 28.6% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 2.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.1 percentage points.
IBEX Limited's operating margin was 6.0% in Q4 2026, reflecting core business profitability. This is down 2.4 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.9 percentage points.
IBEX Limited's net profit margin was 5.3% in Q4 2026, showing the share of revenue converted to profit. This is down 1.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.8 percentage points.
IBEX Limited's ROE was 5.1% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is down 2.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.1 percentage points.
Capital Allocation
IBEX Limited spent $4.2M on share buybacks in Q4 2026, returning capital to shareholders by reducing shares outstanding. This represents an increase of 166.7% from the same quarter a year earlier. Against the prior quarter it is down 7.2%.
IBEX Limited invested $3.2M in capex in Q4 2026, funding long-term assets and infrastructure. This represents a decrease of 38.7% from the same quarter a year earlier. Against the prior quarter it is down 40.0%.
Not reported for Q4 2026.
IBEX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.3M+11.6% | $164.4M+16.8% | $164.2M+16.7% | $151.2M+16.5% | $147.1M+18.2% | $140.7M+11.0% | $140.7M+6.1% | $129.7M+4.1% |
| Cost of Revenue | $117.3M+16.3% | $115.6M+20.4% | $116.6M+18.1% | $106.6M+18.4% | $100.9M+18.2% | $96.0M+10.3% | $98.8M+3.0% | $90.0M+2.1% |
| Gross Profit | $46.9M+1.4% | $48.8M+9.1% | $47.6M+13.5% | $44.6M+12.4% | $46.3M+18.2% | $44.7M+12.6% | $41.9M+14.1% | $39.7M+9.0% |
| SG&A Expenses | $31.5M+5.8% | $27.5M+1.5% | $27.6M+7.2% | $26.5M+1.2% | $29.8M+37.2% | $27.1M+14.8% | $25.7M+3.4% | $26.2M+13.8% |
| Operating Income | $9.8M-19.9% | $16.2M+21.2% | $15.3M+28.2% | $13.7M+50.7% | $12.3M-4.7% | $13.3M+18.1% | $11.9M+71.7% | $9.1M+9.1% |
| EBITDA | $15.4M-6.4% | $21.3M+20.8% | $20.0M+23.6% | $18.1M+34.3% | $16.5M-5.5% | $17.7M+9.4% | $16.2M+36.3% | $13.5M+0.7% |
| Interest Expense | $222K-50.4% | $249K-38.4% | $248K-60.0% | $217K+34.0% | $448K+156.0% | $404K+225.8% | $620K+458.6% | $162K+55.8% |
| Income Tax | $968K-56.9% | $2.6M+6.3% | $2.9M+22.5% | $1.5M-25.8% | $2.2M-33.7% | $2.5M+94.5% | $2.4M+84.7% | $2.0M+42.8% |
| Net Income | $8.7M-8.8% | $13.3M+27.3% | $12.2M+31.8% | $12.0M+59.9% | $9.6M-2.5% | $10.5M+1.5% | $9.3M+52.6% | $7.5M+1.4% |
| EPS (Basic) | $0.65-8.5% | $0.99+25.3% | $0.91+49.2% | $0.90+100.0% | $0.71+24.6% | $0.79+33.9% | $0.61+79.4% | $0.45+9.8% |
| EPS (Diluted) | $0.59-10.6% | $0.89+21.9% | $0.83+45.6% | $0.82+90.7% | $0.66+20.0% | $0.73+28.1% | $0.57+72.7% | $0.43+10.3% |
| Diluted Shares (Avg) | N/A | 15M+4.1% | 15M-10.4% | 15M-16.5% | N/A | 14M-20.1% | 16M-10.8% | 17M-7.5% |
Not reported in any period shown, so not listed: R&D Expenses.
IBEX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $309.1M+13.1% | $297.2M+8.2% | $295.8M+8.6% | $283.9M-7.3% | $273.2M-7.0% | $274.7M-5.1% | $272.5M-8.6% | $306.3M+3.7% |
| Current Assets | $179.6M+23.4% | $165.4M+11.3% | $158.5M-0.3% | $152.8M-19.0% | $145.6M-19.1% | $148.7M-13.2% | $159.0M-6.2% | $188.5M+12.5% |
| Cash & Equivalents | $32.6M+112.2% | $15.4M+18.7% | $15.5M-23.5% | $22.7M-63.6% | $15.3M-75.5% | $13.0M-74.4% | $20.2M-58.8% | $62.3M+0.4% |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Receivable | $125.3M+7.0% | $129.2M+7.6% | $130.5M+8.2% | $116.0M+9.4% | $117.1M+19.1% | $120.0M+16.2% | $120.6M+15.1% | $106.0M+17.7% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% | $11.8M0.0% |
| Total Liabilities | $138.9M0.0% | $136.5M-9.4% | $141.3M-13.6% | $140.2M+3.7% | $138.9M+8.4% | $150.6M+15.6% | $163.6M+15.1% | $135.2M-3.1% |
| Current Liabilities | $85.5M+7.0% | $84.8M-4.7% | $86.5M-21.8% | $84.0M+8.0% | $79.9M+12.6% | $89.0M+25.8% | $110.6M+49.0% | $77.8M+5.5% |
| Non-Current Liabilities | $53.4M-9.5% | $51.7M-16.0% | $54.8M+3.5% | $56.2M-2.1% | $59.0M+3.2% | $61.5M+3.4% | $52.9M-22.0% | $57.4M-12.6% |
| Long-Term Debt | $777K-2.4% | $572K-22.2% | $594K-14.5% | $726K-9.5% | $796K-8.2% | $735K-10.4% | $695K+24.1% | $802K+38.0% |
| Total Equity | $170.2M+26.7% | $160.8M+29.5% | $154.5M+41.8% | $143.6M-16.1% | $134.3M-19.0% | $124.2M-22.1% | $108.9M-30.2% | $171.1M+9.6% |
| Retained Earnings | $72.1M+180.0% | $63.3M+292.2% | $50.0M+780.9% | $37.8M+1151.9% | $25.7M+331.4% | $16.1M+177.0% | $5.7M+118.1% | -$3.6M+90.4% |
Not reported in any period shown, so not listed: Inventory.
IBEX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $24.8M-11.1% | $11.9M+34.4% | $6.6M+482.3% | $15.7M+101.9% | $27.9M+60.4% | $8.8M-22.8% | $1.1M+169.7% | $7.8M-10.6% |
| Depreciation & Amortization | $5.6M+32.4% | $5.2M+19.4% | $4.8M+10.8% | $4.4M+0.2% | $4.2M-7.8% | $4.3M-11.0% | $4.3M-13.3% | $4.4M-13.3% |
| Stock-Based Compensation | N/A | $788K-50.8% | $1.1M-9.8% | $2.5M+280.6% | N/A | $1.6M+243.6% | $1.2M-13.5% | $670K-21.0% |
| Capital Expenditures | $3.2M-38.7% | $5.3M+0.1% | $11.7M+171.6% | $7.6M+110.4% | $5.2M+132.4% | $5.3M+211.5% | $4.3M+49.3% | $3.6M+76.9% |
| Free Cash Flow | $21.7M-4.9% | $6.6M+85.1% | -$5.1M-60.1% | $8.0M+94.4% | $22.8M+49.8% | $3.6M-63.4% | -$3.2M+29.8% | $4.1M-37.7% |
| Investing Cash Flow | -$3.2M+38.7% | -$5.3M-0.1% | -$11.7M-171.6% | -$7.6M-110.4% | -$5.2M-132.4% | -$5.3M-211.5% | -$4.3M-49.3% | -$3.6M-76.9% |
| Financing Cash Flow | -$4.5M+77.9% | -$6.7M+39.1% | -$2.1M+94.5% | -$647K+85.9% | -$20.2M-542.3% | -$10.9M-35.5% | -$38.9M-354.9% | -$4.6M-133.7% |
| Share Buybacks | $4.2M+166.7% | $4.6M-81.7% | $2.8M-94.0% | $2.8M-42.4% | $1.6M-47.0% | $25.1M+202.7% | $46.6M+451.6% | $4.8M+162.4% |
Not reported in any period shown, so not listed: Dividends Paid.
IBEX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.6%-2.9pp | 29.7%-2.1pp | 29.0%-0.8pp | 29.5%-1.1pp | 31.4%0.0pp | 31.8%+0.5pp | 29.8%+2.1pp | 30.6%+1.4pp |
| Operating Margin | 6.0%-2.4pp | 9.8%+0.4pp | 9.3%+0.8pp | 9.1%+2.1pp | 8.3%-2.0pp | 9.5%+0.6pp | 8.5%+3.2pp | 7.0%+0.3pp |
| Net Margin | 5.3%-1.2pp | 8.1%+0.7pp | 7.4%+0.8pp | 8.0%+2.2pp | 6.5%-1.4pp | 7.4%-0.7pp | 6.6%+2.0pp | 5.8%-0.2pp |
| Return on Equity | 5.1%-2.0pp | 8.3%-0.1pp | 7.9%-0.6pp | 8.4%+4.0pp | 7.1%+1.2pp | 8.4%+2.0pp | 8.5%+4.6pp | 4.4%-0.4pp |
| Return on Assets | 2.8%-0.7pp | 4.5%+0.7pp | 4.1%+0.7pp | 4.2%+1.8pp | 3.5%+0.2pp | 3.8%+0.3pp | 3.4%+1.4pp | 2.5%-0.1pp |
| Current Ratio | 2.10+0.3x | 1.95+0.3x | 1.83+0.4x | 1.82-0.6x | 1.82-0.7x | 1.67-0.8x | 1.44-0.8x | 2.42+0.2x |
| Debt-to-Equity | 0.000.0x | 0.000.0x | 0.000.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.010.0x | 0.000.0x |
| Asset Turnover | 0.530.0x | 0.550.0x | 0.560.0x | 0.53+0.1x | 0.54+0.1x | 0.51+0.1x | 0.52+0.1x | 0.420.0x |
| FCF Margin | 13.2%-2.3pp | 4.0%+1.5pp | -3.1%-0.8pp | 5.3%+2.1pp | 15.5%+3.3pp | 2.5%-5.1pp | -2.3%+1.1pp | 3.2%-2.1pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| IBEX Limited IBEX | FY2026 | $644.1M | $46.3M | 7.2% | $601.1M | 71/100 |
| TSS, Inc. TSSI | FY2025 | $245.7M | $15.1M | 6.2% | $260.2M | 57/100 |
| Xerox Holdings Corporation XRX | FY2025 | $7.0B | -$1.0B | -14.6% | $355.9M | 19/100 |
| Conduent Incorporated CNDT | FY2025 | $3.0B | -$170.0M | -5.6% | $231.7M | 21/100 |
| TechTarget, Inc. TTGT | FY2025 | $486.8M | -$1.0B | N/A | $278.5M | 36/100 |
| LZ Technology Holdings Limited LZMH | FY2025 | $161.4M | -$24.8M | -15.4% | $9.4M | 30/100 |
Where IBEX Limited Ranks
Frequently Asked Questions
What is IBEX Limited's annual revenue?
IBEX Limited (IBEX) reported $644.1M in total revenue for fiscal year 2026. This represents a 15.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is IBEX Limited's revenue growing?
IBEX Limited (IBEX) revenue grew by 15.4% year-over-year, from $558.3M to $644.1M in fiscal year 2026.
Is IBEX Limited profitable?
Yes, IBEX Limited (IBEX) reported a net income of $46.3M in fiscal year 2026, with a net profit margin of 7.2%.
What is IBEX Limited's EBITDA?
IBEX Limited (IBEX) had EBITDA of $74.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does IBEX Limited have?
As of fiscal year 2026, IBEX Limited (IBEX) had $32.6M in cash and equivalents against $777K in long-term debt.
What is IBEX Limited's gross margin?
IBEX Limited (IBEX) had a gross margin of 29.2% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is IBEX Limited's operating margin?
IBEX Limited (IBEX) had an operating margin of 8.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is IBEX Limited's net profit margin?
IBEX Limited (IBEX) had a net profit margin of 7.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is IBEX Limited's return on equity (ROE)?
IBEX Limited (IBEX) has a return on equity of 27.2% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is IBEX Limited's free cash flow?
IBEX Limited (IBEX) generated $31.2M in free cash flow during fiscal year 2026. This represents a 14.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is IBEX Limited's operating cash flow?
IBEX Limited (IBEX) generated $59.0M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are IBEX Limited's total assets?
IBEX Limited (IBEX) had $309.1M in total assets as of fiscal year 2026, including both current and long-term assets.
What are IBEX Limited's capital expenditures?
IBEX Limited (IBEX) invested $27.8M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is IBEX Limited's current ratio?
IBEX Limited (IBEX) had a current ratio of 2.10 as of fiscal year 2026, which is generally considered healthy.
What is IBEX Limited's debt-to-equity ratio?
IBEX Limited (IBEX) had a debt-to-equity ratio of 0.00 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is IBEX Limited's return on assets (ROA)?
IBEX Limited (IBEX) had a return on assets of 15.0% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is IBEX Limited's P/E ratio?
IBEX Limited (IBEX) trades at 13.0x earnings, its market capitalization divided by net income of $46.3M net income, FY2026. The market capitalization is $601.1M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IBEX Limited's price-to-sales ratio?
IBEX Limited (IBEX) trades at 0.9x sales, its market capitalization divided by revenue of $644.1M revenue, FY2026. The market capitalization is $601.1M as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is IBEX Limited's Altman Z-Score?
IBEX Limited (IBEX) has an Altman Z-Score of 5.96, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is IBEX Limited's Piotroski F-Score?
IBEX Limited (IBEX) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are IBEX Limited's earnings high quality?
IBEX Limited (IBEX) has an earnings quality ratio of 1.27x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can IBEX Limited cover its interest payments?
IBEX Limited (IBEX) has an interest coverage ratio of 58.72x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is IBEX Limited?
IBEX Limited (IBEX) scores 71 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.